In-home HIV test

Shares of OraSure Technologies Inc. rose to their highest in more than ten years after U.S. health regulators approved its in-home HIV test on July 3, the first such product to get the nod.

Shares of OraSure Technologies Inc. rose to their highest in more than ten years after U.S. health regulators approved its in-home HIV test on July 3, the first such product to get the nod. (OraSure Technologies, Inc., Getty Images)

Shares of OraSure Technologies Inc. rose to their highest in more than ten years after U.S. health regulators approved its in-home HIV test on July 3, the first such product to get the nod.OraSure Technologies, Inc., Getty Images